Danish Renewable Energy Stock News

Vestas Wind Systems (CPSE:VWS) opened 2026 with Q1 revenue of €3.97b and basic EPS of €0.08, setting the tone for how the year is starting after a busy 2025. Over recent quarters, the company has seen quarterly revenue move from €3.47b and EPS of roughly €0.00 in Q1 2025 to €6.27b and €0.44 in Q4 2025, with trailing twelve month EPS at €0.83 on €19.32b of revenue. This gives investors a clear read on how volumes and profitability are feeding through to the income line as net margins sit at...

Novo Nordisk (CPSE:NOVO B) opened 2026 with Q1 revenue of DKK 96.8b and basic EPS of DKK 10.93, while the trailing twelve months show revenue of DKK 327.8b and EPS of DKK 27.44. Over the past year, revenue has moved from DKK 290.4b to DKK 327.8b and EPS from DKK 22.67 to DKK 27.44 on a trailing basis. This sets a clear benchmark for how current profitability aligns with investor expectations. With net margin running at 37.2% versus 34.5% a year earlier, the latest results put the focus...

Pandora (CPSE:PNDORA) opened 2026 with Q1 revenue of DKK 7.1b and basic EPS of DKK 12.6, alongside net income of DKK 942m, setting a clear marker for how the year is starting after a busy 2025. Over recent quarters the company has seen revenue move between DKK 6.3b and DKK 11.9b, while basic EPS has ranged from DKK 6.3 to DKK 37. This gives you a broad view of how the top and bottom line have tracked through different trading periods. With a trailing net profit margin of 15.7%, the latest...

Q1 2026 results set up a mixed but interesting picture Netcompany Group (CPSE:NETC) has kicked off 2026 with Q1 revenue of DKK 2.4b and basic EPS of DKK 3.15, putting fresh numbers on the table for a stock trading around DKK 356.8. Over the past six reported quarters, revenue has moved from DKK 1.7b in Q4 2024 to DKK 2.4b in Q1 2026. Quarterly EPS has ranged from a loss of DKK 1.44 in Q3 2025 to DKK 3.21 in Q4 2025 and DKK 3.15 in the latest quarter, setting up a results season where...

DSV (CPSE:DSV) just opened 2026 with first quarter results that paired higher sales with lower profitability, while management kept full year EBIT guidance intact, including expected Schenker related synergies. See our latest analysis for DSV. The stock is trading at DKK1,504.5, with a 1 day share price return of 3.47% but a 90 day share price return reflecting an 18.37% decline. Meanwhile, the 1 year total shareholder return of 4.36% and 3 year total shareholder return of 16.58% point to...

This article examines whether Alm. Brand is attractively priced or if the current share price already reflects most of its potential, by breaking down what the current valuation signals may indicate about the stock. The share price recently closed at kr.15.26, with returns of 1.7% over the past week, a 3.6% decline over the last month, and a 1.4% gain over the past year, alongside a 42.0% three year and 13.2% five year return profile. These moves sit against a backdrop of ongoing coverage...

Ringkjøbing Landbobank stock snapshot after recent moves Ringkjøbing Landbobank (CPSE:RILBA) has attracted fresh attention after recent price moves, with the stock showing mixed short term performance alongside longer term total returns and measurable annual growth in revenue and net income. See our latest analysis for Ringkjøbing Landbobank. Recent trading has been relatively steady, with a 1 day share price return of 1.09% and a 7 day share price return of 1.15%. The 1 year total...

DFDS Q1 2026 results set the tone for a profit-focused turnaround story DFDS (CPSE:DFDS) has opened 2026 with Q1 revenue of DKK 7.4b and a basic EPS loss of DKK 3.29, alongside a trailing twelve month net loss of DKK 276m and EPS of DKK 5.11 in the red, which keeps the focus squarely on the path back to profitability. Over recent quarters the company has seen revenue move between DKK 7.2b and DKK 8.3b, while EPS has swung from a loss of DKK 6.09 to a profit of DKK 5.13 before reverting to...

Q1 2026 results set the tone for NTG Nordic Transport Group (CPSE:NTG) NTG Nordic Transport Group (CPSE:NTG) opened 2026 with Q1 revenue of DKK 2,983 million and basic EPS of DKK 2.62, framing the latest quarterly read alongside a trailing twelve month EPS of DKK 10.14 on revenue of DKK 11.67 billion. Over the past year, the company has seen revenue move from DKK 9.35 billion in the trailing twelve months to Q4 2024 to DKK 11.67 billion by Q1 2026, while trailing EPS shifted from DKK 13.94 to...

Maersk's U.S.-flagged vessel Fairfax completed a safe transit of the Strait of Hormuz after being stuck in the Persian Gulf for months. The passage, supported by military escort, marks a key operational development for A.P. Møller Mærsk (CPSE:MAERSK B) in a high-risk shipping corridor. This update adds new detail to the company’s recent experience with Middle East route disruptions and security challenges. A.P. Møller Mærsk, listed as CPSE:MAERSK B, is a global container shipping and...

Trifork Group (CPSE:TRIFOR) has just posted its Q1 2026 scorecard, with recent quarterly context showing Q4 2025 revenue of €59.1 million, basic EPS of €0.44 and net income of €8.5 million. The trailing twelve months to Q4 2025 came in at €221.2 million of revenue, basic EPS of €0.53 and net income of €10.3 million. Over the past few reported quarters, revenue has moved between €47.2 million and €59.1 million, with basic EPS ranging from a slight loss of €0.01 to €0.63 and net income...

Novozymes (CPSE:NSIS B) has opened Q1 2026 earnings season with recent quarterly revenue between €981.4 million and €1.08 billion over the past six reported periods, while quarterly EPS ranged from €0.26 to €0.40, and trailing twelve month EPS most recently sat at €1.25 on €4.16 billion of revenue. Over that stretch, revenue has moved from €3.83 billion and EPS of €1.10 on a trailing basis in Q4 2024 to €4.16 billion and EPS of €1.25 by Q4 2025. With trailing net profit margin at 14% compared...

Rockwool stock snapshot after recent performance Rockwool (CPSE:ROCK B) has drawn investor attention after a year of mixed share performance, with the stock showing a return of about 0.6% over the past day but a 39% decline over the past year. See our latest analysis for Rockwool. With the share price at DKK180.8, Rockwool’s recent 1 day share price return of 0.56% sits against a weaker trend, including a 90 day share price return of a 21% decline and a 1 year total shareholder return of a...

If you are trying to figure out whether Novo Nordisk is attractively priced or not, the stock's recent moves and current valuation checks give you a lot to work with. The share price recently closed at kr.286.25, with a 7 day return of 8.0%, 30 day return of 20.8%, a year to date return showing a 13.3% decline, and a 1 year return showing a 32.1% decline, which may suggest changing views on both opportunity and risk. Recent headlines have continued to spotlight Novo Nordisk's role in...

Dampskibsselskabet Norden (CPSE:DNORD) lifted its 2026 full year net profit guidance to a range of US$70 million to US$140 million, up from US$30 million to US$100 million, a shift many investors will scrutinize closely. See our latest analysis for Dampskibsselskabet Norden. The upgraded 2026 profit guidance comes as the stock trades at DKK316.0, with a 90-day share price return of 26.91% and a 1-year total shareholder return of 70.98%, suggesting momentum has been building over both shorter...

ALK-Abelló (CPSE:ALK B) has opened 2026 with Q1 revenue of DKK 1.8b and basic EPS of DKK 2, set against trailing twelve month revenue of DKK 6.6b and EPS of about DKK 5.8 as the company builds on a year in which earnings grew 36.6%. Over the past year, revenue has moved from DKK 5.5b to DKK 6.6b and trailing EPS has progressed from roughly DKK 3.7 to DKK 5.8, while net profit margin has lifted from 16.4% to 19.5%. This gives the latest quarter a firm profitability backdrop for investors...

Recent share performance and business profile FLSmidth (CPSE:FLS) has drawn investor attention after a period of weaker share performance, with the stock showing declines over the past week, month and past 3 months despite a positive 1 year total return. The Copenhagen based mining equipment and services company reports annual revenue of DKK 14,612.0 million and net income of DKK 706.0 million, with operations spread across service, product and pumps, cyclones & valves segments worldwide. See...

Q1 earnings highlight Embla Medical hf (CPSE:EMBLA) performance shift Embla Medical hf (CPSE:EMBLA) has drawn fresh attention after reporting first quarter 2026 earnings, with sales of US$232.4 million and net income of US$14.46 million compared with the same period a year earlier. See our latest analysis for Embla Medical hf. At a share price of DKK27.25, Embla Medical hf has seen a 1-day share price return of 1.87%, while its 90-day share price return of 14.04% and 1-year total shareholder...

As the pan-European STOXX Europe 600 Index ended the week broadly flat amid stalled geopolitical negotiations and fluctuating oil prices, investors are keenly observing potential opportunities in undervalued stocks. In this context, identifying stocks that might be priced below their estimated value can be crucial for those looking to capitalize on positive earnings momentum despite broader economic uncertainties.

GN Store Nord A/S ( CPH:GN ) shareholders will have a reason to smile today, with the analysts making substantial...

Aktieselskabet Schouw (CPSE:SCHO) drew investor attention after first quarter 2026 earnings showed lower sales of DKK 7,699 million, higher net income of DKK 165 million, and improved earnings per share. See our latest analysis for Aktieselskabet Schouw. At a share price of DKK680.0, the stock has a 7 day share price return of 5.92% and a 1 year total shareholder return of 22.85%. This suggests momentum has been building as investors react to the Q1 earnings update and the planned BioMar...

Royal Unibrew (CPSE:RBREW) is back in focus after disclosing that its PepsiCo license agreements for Denmark, Finland, and the Baltic states, currently about 13% of net revenue, will expire at the end of 2028. See our latest analysis for Royal Unibrew. Despite the PepsiCo update and a series of recent announcements, including a larger share buyback, AGM approvals and Q1 2026 results, the stock has had a 30 day share price return of a 19.7% decline and a 1 year total shareholder return of a...

Zealand Pharma and Roche have advanced obesity candidate petrelintide into Phase 3 development. Boehringer Ingelheim reported positive Phase III results for obesity drug survodutide, co-invented with Zealand Pharma. Zealand Pharma is eligible for milestone payments and royalties from survodutide, subject to future sales. CPSE:ZEAL is trading at DKK309.0, with the stock down 32.8% year to date and 36.4% over the past 12 months, alongside gains of 39.1% over three years and 57.4% over five...

Recent share moves and business scale Alm. Brand (CPSE:ALMB) has seen mixed returns recently, with the share up 2.9% over the past day but showing declines over the past week, month, and past 3 months. Over longer periods, the stock has delivered a 3.5% 1 year total return and a 44.2% 3 year total return, giving investors context for the recent pullback. The company reported revenue of DKK 13.8b and net income of DKK 1.2b, with both revenue and net income showing annual growth, which helps...